ArticlePLoS computational biology2026
PON-Del predictor for sequence retaining protein deletions.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein deletions are frequent among both disease-causing and tolerated variants. Several mechanisms at the DNA, RNA and protein levels can lead to deletions. Many deletions are misclassified in the literature and databases, especially when the mRNA is degraded by the cellular quality-control mechanism. We developed a novel predictor for sequence retaining protein deletions, i.e., variants that do not alter the sequence downstream of the deletion site. We collected an extensive dataset of verified protein deletions, each described by a comprehensive set of context, content, position, and gene-based features. We evaluated both statistical and deep learning algorithms and selected a gradient boosting-based approach to develop the PON-Del predictor for short, 1-10 amino acid, sequence-retaining deletions. Variants are typically classified into two categories: either pathogenic or benign. However, there is always a third class of variants: variants of uncertain significance (VUSs), which have been ignored by all previous methods. PON-Del is the first deletion interpretation method that includes VUSs. It provides two outputs, binary and three-state prediction with VUSs. The performance of PON-Del was superior to that of previous methods. The tool is freely available at https://structure.bmc.lu.se/pon_del/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.